Inogen (INGN) Capital Expenditures (2013 - 2026)
Inogen (INGN) reported Capital Expenditures of $210000.0 for Q1 2026, down 28.08% year-over-year from $292000.0 in Q1 2025, and down 17.65% quarter-over-quarter from $255000.0 in Q4 2025.
Inogen (INGN) Capital Expenditures (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Capital Expenditures data on file, last reported at $210000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $210000.0, down 28.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $327000.0 (down 86.04% YoY), and the FY2025 annual result was $409000.0, down 87.83% from the prior year.
- Capital Expenditures declined to $210000.0 in Q1 2026 per INGN's latest filing, from $255000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.7 million in Q3 2023 and troughed at -$3.6 million in Q4 2023.
- A 5-year average of $442352.9 and a median of $210000.0 in 2026 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 1915.38% in 2024 and fell as far as 2358.0% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $3.0 million in 2022, then plunged by 219.75% to -$3.6 million in 2023, then jumped by 191.1% to $3.3 million in 2024, then plunged by 92.27% to $255000.0 in 2025, then fell by 17.65% to $210000.0 in 2026.
- Business Quant data shows INGN's Capital Expenditures at $210000.0 in Q1 2026, $255000.0 in Q4 2025, and -$822000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | -822,000.00 |
| Sep 30, 2025 | -822,000.00 |
| Jun 30, 2025 | 684,000.00 |
| Jun 30, 2025 | 684,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | 3.30 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | -119,000.00 |
| Sep 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -1.13 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | -3.62 Mn |
| Dec 31, 2023 | -3.62 Mn |